RESUMEN

The authors administered 45-90 mg/day of tacrine to eight patients with tardive dyskinesia. After 2 weeks of treatment, there was a mean reduction in tardive dyskinesia scores of 43%. No improvement occurred when a placebo was used instead of tacrine.

Asunto(s)

Aminoacridinas/uso terapéutico , Discinesia Inducida por Medicamentos/tratamiento farmacológico , Tacrina/uso terapéutico , Administración Oral , Adulto , Discinesia Inducida por Medicamentos/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tacrina/administración & dosificación